| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/04/2002 | WO2001062799A3 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 04/04/2002 | WO2001062792A3 Cancer treatment and prognosis involving hes-1 protein |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001059113A3 G-protein coupled receptor proteins and nucleic acids encoding same |
| 04/04/2002 | WO2001058494A3 Gene therapy for treating ocular-related disorders |
| 04/04/2002 | WO2001057185A3 Novel molecules of the card-related protein family and uses thereof |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001053354A3 Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001044277A3 Herbicide target genes and methods |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 04/04/2002 | WO2001012232A3 Process to make a sustained release formulation |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000064261A9 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof |
| 04/04/2002 | WO2000058359A9 Retro-inverso prosaposin-derived peptides and use thereof |
| 04/04/2002 | WO2000047740A9 Tnf-related proteins |
| 04/04/2002 | US20020040490 For producing genetically modified cells which is used for screening a candidate agent for its biological effect |
| 04/04/2002 | US20020040489 Expressed sequences of arabidopsis thaliana |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040483 Contacting a test compound to a nematode; and monitoring a female sexual maturation of the nematode, wherein inhibition of the female sexual maturation indicates that the test compound includes the anti-nematode agent |
| 04/04/2002 | US20020040275 Proteomic analysis |
| 04/04/2002 | US20020040133 Epstein barr virus induced genes |
| 04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
| 04/04/2002 | US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 04/04/2002 | US20020040128 Carbohydrate-blood protein complex for us as an oxygen transporter |
| 04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
| 04/04/2002 | US20020040010 Use of agents to treat heart disorders |
| 04/04/2002 | US20020040008 Administering agent for inhibiting interaction between P-selectin and a ligand of P-selectin |
| 04/04/2002 | US20020040001 Pharmaceutical compositions comprising a soluble laminin receptor precursor or a compound which blocks the interaction of the laminin receptor precursor and PrPSc or PrPc |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039999 Antinociceptive agent derivative |
| 04/04/2002 | US20020039992 Tek antagonists |
| 04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | US20020039779 Transcriptional regulator |
| 04/04/2002 | US20020039776 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039765 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 04/04/2002 | US20020039764 Nucleic, acids, proteins, and antibodies |
| 04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
| 04/04/2002 | US20020039762 26908 novel G protein-coupled receptors and uses therefor |
| 04/04/2002 | US20020039760 Nucleotide sequences coding preferential polypeptides for use in treatment of blood disorders, cancer and thrombocytopenia |
| 04/04/2002 | US20020039759 Polypeptide for use in the prevention of bacterial infection |
| 04/04/2002 | US20020039755 Conjugate vaccine against gram-negative bacterial infections |
| 04/04/2002 | US20020039749 Analyzing using phosphated tyrosine compound |
| 04/04/2002 | US20020039748 Protein; for use in the treatment of blood disorders; for prevention of infection; wound healing agent |
| 04/04/2002 | US20020039735 Monoclonal antibodies to ING1 isoforms |
| 04/04/2002 | US20020039731 Nucleotide sequences for use in the diagnosis, detection and treatment of cancer |
| 04/04/2002 | US20020039729 Methods & compositions for identifying a protease |
| 04/04/2002 | US20020039727 Nucleotide sequences for use in the diagnosis and detection of cancer |
| 04/04/2002 | US20020039589 Veterinary medicine; against Pasteurella caused disease |
| 04/04/2002 | US20020039588 Compounds and methods for the treatment and prevention of bacterial infection |
| 04/04/2002 | US20020039586 Lyme disease |
| 04/04/2002 | US20020039585 Mutants of streptococcal toxin c and methods of use |
| 04/04/2002 | US20020039584 Vaccine |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 04/04/2002 | US20020039578 Methods for treating disease with antibodies to CXCR3 |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | US20020039574 Delivery of therapeutic gene products by intestinal cell expression |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | DE10043937A1 Production of trivalent chromium complex compound useful for preparing milk product for controlling blood sugar involves addition of lactoferrin or whey protein to a trivalent chromium compound |
| 04/04/2002 | DE10041126A1 DNA-bindende Peptiddomänen und ein Verfahren zur Bereitstellung solcher Domänen DNA-binding peptide domains, and a method for providing such domains |
| 04/04/2002 | CA2760906A1 Sbmu200 gene and male tissue-prefered promotor, regulatory regions and methods of use in mediating plant male fertility |
| 04/04/2002 | CA2424014A1 A novel human g-protein coupled receptor, hgprbmy7, expressed highly in spinal cord |
| 04/04/2002 | CA2424004A1 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423954A1 A novel human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 04/04/2002 | CA2423942A1 Human ion-exchanger proteins and polynucleotides encoding the same |
| 04/04/2002 | CA2423922A1 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 04/04/2002 | CA2423863A1 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer) |
| 04/04/2002 | CA2423797A1 Antibodies to the propeptide of candida albicans and methods of use |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423492A1 A fibrin/fibrinogen-binding conjugate |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2422891A1 Novel proteins and nucleic acids encoding same |
| 04/04/2002 | CA2422846A1 Lymphoma associated molecules and uses therefor |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2422099A1 Identification of neuroblastoma tumor suppressor genes |
| 04/04/2002 | CA2421851A1 Tgf-.beta. inhibitors and methods |
| 04/04/2002 | CA2421620A1 Promoter sequences |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2420415A1 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/04/2002 | CA2420045A1 Melanocortin receptor ligands |
| 04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/03/2002 | EP1193313A1 Method for determining hiv-1 subtype |
| 04/03/2002 | EP1193312A1 Novel psychrotrophic bacterium and dna probe for detecting the bacterium |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192279A2 Diagnostics and therapeutics for cardiovascular disorders |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192273A2 Method for detecting mismatches or mutations in nucleic acid |
| 04/03/2002 | EP1192268A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |